Premier Closes $2.6B Take-Private Deal with Patient Square Capital

Premier, a leading healthcare services and group purchasing organization, has officially gone private in a $2.6 billion acquisition by Patient Square Capital, a healthcare-focused investment firm. The deal, which closed earlier than anticipated on November 26, 2025, marks the end of Premier's decade-long run as a public company on the Nasdaq stock exchange.
Deal Structure and Financial Details
Under the terms of the agreement, Premier stockholders will receive $28.25 in cash per share. The acquisition, initially announced in September, values the company at $2.6 billion and comes after years of strategic review by Premier's management.
The closure of this deal represents a significant shift for Premier, which has faced financial headwinds and declining revenue in recent years. In its last reported quarter ending September 30, Premier saw a 3% year-over-year decline in revenue to $240 million, with net income from continuing operations plummeting 79% to $15.3 million from $72.9 million in the prior-year period.
Corporate Restructuring and Asset Divestiture
As part of its strategic realignment, Premier has undergone significant restructuring:
- The company has divested its non-healthcare GPO operations and holdings in S2S Global, a healthcare and foodservice company.
- Premier is in the process of winding down operations at Contigo Health, its employee health benefits subsidiary.
- The board of directors has resigned as part of the purchase agreement, with CEO Michael Alkire and CFO Glenn Coleman remaining as directors of the now privately held entity.
Premier will continue to operate as a wholly owned subsidiary of Patient Square Capital, leveraging its new owner's expertise in healthcare investments to navigate the evolving landscape of healthcare services and technology.
Industry Implications and Patient Square's Portfolio
The acquisition of Premier adds a significant asset to Patient Square Capital's healthcare-focused portfolio, which includes:
- ChenMed, a value-based primary care provider
- Access Telecare, an acute care telemedicine firm
- CorroHealth, a revenue cycle management company
This strategic move by Patient Square Capital underscores the growing trend of private equity investments in healthcare services and technology companies, as investors seek to capitalize on the sector's transformation and potential for innovation.
References
- Premier closes $2.6B take-private deal
The healthcare services and group purchasing organization stopped trading on Nasdaq Tuesday after more than a decade on the public markets.
Explore Further
What specific strategies are Patient Square Capital likely to employ to address Premier's declining revenue and financial performance?
How does Premier's restructuring, including divestiture of non-healthcare GPO operations, align with Patient Square Capital's investment priorities?
What impact might the acquisition of Premier have on the competitive landscape of group purchasing organizations within the healthcare sector?
What synergies exist between Premier and other healthcare-focused entities in Patient Square Capital’s portfolio, such as ChenMed and Access Telecare?
How does the trend of private equity investments in healthcare services and technology companies influence innovation and long-term growth in the sector?